TY - JOUR
T1 - Coronary Functional Abnormalities in Patients With Angina and Nonobstructive Coronary Artery Disease
AU - Suda, Akira
AU - Takahashi, Jun
AU - Hao, Kiyotaka
AU - Kikuchi, Yoku
AU - Shindo, Tomohiko
AU - Ikeda, Shohei
AU - Sato, Koichi
AU - Sugisawa, Jun
AU - Matsumoto, Yasuharu
AU - Miyata, Satoshi
AU - Sakata, Yasuhiko
AU - Shimokawa, Hiroaki
N1 - Funding Information:
This study was supported in part by the grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Publisher Copyright:
© 2019 American College of Cardiology Foundation
PY - 2019/11/12
Y1 - 2019/11/12
N2 - Background: Approximately one-half of patients undergoing diagnostic coronary angiography for angina have no significant coronary stenosis, in whom coronary functional abnormalities could be involved. Objectives: This study examined the significance of coronary functional abnormalities in a comprehensive manner for both epicardial and microvascular coronary arteries in patients with angina and nonobstructive coronary artery disease (CAD). Methods: This study prospectively enrolled 187 consecutive patients (male/female 113/74, 63.2 ± 12.3 years), who underwent acetylcholine provocation test for coronary spasm and measurement of index of microcirculatory resistance (IMR) to evaluate coronary microvascular function, and followed them for a median of 893 days. Results: Of all subjects, acetylcholine test identified 128 patients with vasospastic angina (VSA) (68%), and cardiac events occurred in 10 patients (5.3%) during the follow-up. Multivariable analysis revealed that IMR correlated with the incidence of cardiac events (hazard ratio: 1.05; 95% confidence interval: 1.02 to 1.09; p = 0.002) and receiver-operating characteristics (ROC) curve analysis identified IMR of 18.0 as the optimal cut-off value. Among the 4 groups based on the cut-off value of IMR and the presence of VSA, the Kaplan-Meier survival analysis showed a significantly worse prognosis in the group with high IMR (≥18.0) and VSA compared with other groups (log rank, p = 0.002). Importantly, intracoronary administration of fasudil, a Rho-kinase inhibitor, significantly ameliorated IMR in the VSA patients with increased IMR (p < 0.0001). Conclusions: These results indicate that in patients with angina and nonobstructive CAD, coexistence of epicardial coronary spasm and increased microvascular resistance is associated with worse prognosis, for which Rho-kinase activation may be involved.
AB - Background: Approximately one-half of patients undergoing diagnostic coronary angiography for angina have no significant coronary stenosis, in whom coronary functional abnormalities could be involved. Objectives: This study examined the significance of coronary functional abnormalities in a comprehensive manner for both epicardial and microvascular coronary arteries in patients with angina and nonobstructive coronary artery disease (CAD). Methods: This study prospectively enrolled 187 consecutive patients (male/female 113/74, 63.2 ± 12.3 years), who underwent acetylcholine provocation test for coronary spasm and measurement of index of microcirculatory resistance (IMR) to evaluate coronary microvascular function, and followed them for a median of 893 days. Results: Of all subjects, acetylcholine test identified 128 patients with vasospastic angina (VSA) (68%), and cardiac events occurred in 10 patients (5.3%) during the follow-up. Multivariable analysis revealed that IMR correlated with the incidence of cardiac events (hazard ratio: 1.05; 95% confidence interval: 1.02 to 1.09; p = 0.002) and receiver-operating characteristics (ROC) curve analysis identified IMR of 18.0 as the optimal cut-off value. Among the 4 groups based on the cut-off value of IMR and the presence of VSA, the Kaplan-Meier survival analysis showed a significantly worse prognosis in the group with high IMR (≥18.0) and VSA compared with other groups (log rank, p = 0.002). Importantly, intracoronary administration of fasudil, a Rho-kinase inhibitor, significantly ameliorated IMR in the VSA patients with increased IMR (p < 0.0001). Conclusions: These results indicate that in patients with angina and nonobstructive CAD, coexistence of epicardial coronary spasm and increased microvascular resistance is associated with worse prognosis, for which Rho-kinase activation may be involved.
KW - IMR
KW - Rho-kinase
KW - coronary spasm
KW - microvascular dysfunction
KW - nonobstructive coronary artery disease
UR - http://www.scopus.com/inward/record.url?scp=85074143385&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85074143385&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2019.08.1056
DO - 10.1016/j.jacc.2019.08.1056
M3 - Article
C2 - 31699275
AN - SCOPUS:85074143385
SN - 0735-1097
VL - 74
SP - 2350
EP - 2360
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 19
ER -